Tags & Categorías

New Research Investigates Shelf Life, Device Usability of Biosimilar Adalimumab

Samsung Bioepis’ biosimilar adalimumab, SB5, has been approved in the European Union under the name Imraldi on the basis of clinical studies includi...

Long-term follow-up of switching to biosimilar infliximab

A study of long-term follow-up data after switching to biosimilar infliximab appears to show identical retention rates, according to French researcher...

Celltrion Says Its Biosimilar Has Gained 56% of the European Infliximab Market

Biosimilar developer Celltrion has seen strong success with its biosimilar infliximab, CT-P13, which is marketed in the United States as Inflectra and...

J&J and Biogen Discuss Their Biosimilar Strategies at J.P. Morgan Healthcare Conference

Presenters during the 37th annual J.P. Morgan Healthcare Conference, held January 7-10 in San Francisco, California provided an overview about what po...

Pfizer and Teva Provide a Look at Their Biosimilar Ambitions on Day 1 of the J.P. Morgan Healthcare ...

During the first day of the 37th Annual J.P. Morgan Healthcare Conference, held January 7-10 in San Francisco, California, 2 major biosimilar develope...

EMA, a la cabeza en Biosimilares

La agencia regulatoria de Europa, la EMA, está a la cabeza en materia de biosimilares aprobados.

Biosim seguirá trabajando con la Administración para promover el uso de los biosimilares en 2019

La Asociación Española de Medicamentos Biosimilares (BioSim) ha informado de la celebración de la reunión de su Consejo Asesor, órgano compuesto ...

Pfizer Gains Positive CHMP Opinion for Bevacizumab Biosimilar, Withdraws "Skinny Label" Adalimumab A...

On Friday, Pfizer announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinio...

Estudios sobre intercambios de biológicos por biosimilares muestran que no se pierde eficacia ni seg...

La página web del Centro Nacional de Información Biotecnológica de Estados Unidos, dependiente del National Instutes for Health (NIH), ha hecho pú...